Royer Corp. and Poly Group LLC finalized an exclusive partnership in late June that results in the manufacture of antimicrobial custom plastic injection molded parts in Madison, Indiana.

Nouvex antimicrobial technology was discovered at Purdue University by a group led by Jeffrey Youngblood, a professor in Purdue’s School of Materials Engineering. Poly Group LLC holds an exclusive, worldwide license to the IP covering Nouvex, which includes a granted U.S. patent.

“It is rewarding to see our technology go to the market and help make a difference, particularly during this worldwide pandemic,” Youngblood said.

Royer Corp., a Madison-based manufacturer, serves a variety of industries that will benefit from an antimicrobial option – especially given the new safety challenges businesses are facing because of the COVID-19 pandemic.

Royer will infuse Nouvex material in a variety of custom injection-molded applications such as airline and mass transit interior parts, food service and hospitality components/disposables, cosmetic applicators, housewares and commercial product pieces.

“Given our company’s unique injection molding capabilities, virtually any custom plastic product can be made in antimicrobial material,” said Roger Williams, CEO of Royer.

The antimicrobial technology marketed as Nouvex has been licensed exclusively and globally to Poly Group by the Purdue Research Foundation Office of Technology Commercialization.

The office is now housed in the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus.